EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gabapentinoids‐duloxetine combination therapy for chronic pain: A mechanism oriented rational to bridge theoretical knowledge and real life setting

Stefania Nobili, Maurizio Evangelista, Elena Lucarini iD, Elena G Giugliano, Carla Ghelardini, Laura Micheli, Lorenzo Di Cesare Mannelli

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70689 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Stefania Nobili und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Chronic Pain, Duloxetine Hydrochloride, Analgesics, Gabapentin. Die Arbeit nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione, dell'Università e della Ricerca, Italian Ministry of Education, University and Research (MIUR), Ministero dell’Istruzione, dell’Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic pain represents a complex debilitating condition that extends beyond the protective function of physiological pain, often persisting as an independent disease entity. Chronic primary and secondary pain syndromes reflect a multifaceted continuum involving nociceptive, neuropathic and nociplastic mechanisms. The maladaptive plasticity of the peripheral and central nervous system (encompassing the ascending and descending pain pathways) sustains hypersensitivity and correlates with comorbid alterations in mood, cognition, sleep and fatigue, underpinned by functional reorganization of brain networks. In this scenario, traditional analgesics frequently demonstrate limited efficacy, while current guidelines recommend antiepileptic agents and antidepressants, particularly gabapentinoids and duloxetine, as first line pharmacological options. This review explores the mechanistic rationale and clinical evidence supporting the combined use of gabapentinoids and duloxetine in chronic pain management. These agents act on distinct yet complementary targets: gabapentinoids reduce excitatory neurotransmission via modulation of calcium channel activity, whereas duloxetine restores descending noradrenergic inhibition and alleviates comorbid symptoms. Clinical trial and meta‐analyses highlight their individual efficacy in diabetic peripheral neuropathy, postherpetic neuralgia and fibromyalgia. Among gabapentinoids, pregabalin exhibits a favourable pharmacokinetic profile that allows rapid titration and demonstrates effectiveness against anxiety‐related sleep disorders. Importantly, emerging evidence suggests that their combination may offer additional benefit, particularly in patients with residual pain despite monotherapy, though evidence remains limited to small, short‐term studies. This review provides proof of concept by bridging theoretical knowledge and real‐life clinical settings aiming to develop treatment protocols based on predominant pain mechanisms that can effectively control hypersensitivity and improve quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic PainDuloxetine HydrochlorideAnalgesicsGabapentinHumansDrug Therapy, CombinationDiabetic NeuropathiesAntidepressive AgentsPregabalinDrug Combinations

Stichwörter der Autor:innen

antidepressantsantiepilepticscombination therapyduloxetinegabapentinoidsneuropathic pain

Substanzen

Duloxetine HydrochlorideAnalgesicsGabapentinAntidepressive AgentsPregabalinDrug Combinations

Autor:innen und Institutionen

  • Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
  • Institute of Anesthesia, Resuscitation and Pain Therapy, Catholic University of Sacred Heart, Rome, Italy.
  • Department of Clinical and Experimental Medicine (DIMED), University of Messina, Messina, Italy.

ORCID-Profile: Elena Lucarini

Förderung

  • Ministero dell'Istruzione, dell'Università e della Ricerca
  • Italian Ministry of Education, University and Research (MIUR)
  • Ministero dell’Istruzione, dell’Università e della Ricerca

Zitieren

APA

Nobili, S., Evangelista, M., Lucarini, E., Giugliano, E. G., Ghelardini, C., Micheli, L., & Di Cesare Mannelli, L. (2026). Gabapentinoids‐duloxetine combination therapy for chronic pain: A mechanism oriented rational to bridge theoretical knowledge and real life setting. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70689

Vancouver

Nobili S, Evangelista M, Lucarini E, Giugliano EG, Ghelardini C, Micheli L, et al. Gabapentinoids‐duloxetine combination therapy for chronic pain: A mechanism oriented rational to bridge theoretical knowledge and real life setting. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70689

BibTeX
@article{Nobili2026,
  author = {Nobili, Stefania and Evangelista, Maurizio and Lucarini, Elena and Giugliano, Elena G and Ghelardini, Carla and Micheli, Laura and Di Cesare Mannelli, Lorenzo},
  title = {Gabapentinoids‐duloxetine combination therapy for chronic pain: A mechanism oriented rational to bridge theoretical knowledge and real life setting},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70689}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche